Hwang back to research?

Hwang Woo-Suk, the disgraced South Korean stem cell scientist, is part of a research team in South Korea requesting permission to work on human embryonic stem cells, the Associated Press linkurl:reported;http://www.iht.com/articles/ap/2007/12/17/asia/AS-GEN-SKorea-Hwang-Stem-Cell.php yesterday. Hwang was one of eight researchers from the Suam Biotechnology Institute, a lab he linkurl:founded;http://www.the-scientist.com/blog/display/23737/ last year, who filed the request, an anonymous official

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Hwang Woo-Suk, the disgraced South Korean stem cell scientist, is part of a research team in South Korea requesting permission to work on human embryonic stem cells, the Associated Press linkurl:reported;http://www.iht.com/articles/ap/2007/12/17/asia/AS-GEN-SKorea-Hwang-Stem-Cell.php yesterday. Hwang was one of eight researchers from the Suam Biotechnology Institute, a lab he linkurl:founded;http://www.the-scientist.com/blog/display/23737/ last year, who filed the request, an anonymous official at the South Korean Health Ministry's bioethics and safety bureau told the linkurl:Agence France-Presse.;http://www.breitbart.com/article.php?id=071217172731.jr1c7zwb&show_article=1 Jung Tae-gil, an official at the Ministry, told the AP that the Ministry will decide by April 2008 whether to approve the request. Hwang is still on trial for linkurl:fabricating;http://www.the-scientist.com/news/display/22933/ data on his work on human cloning. He linkurl:left his post;http://www.the-scientist.com/article/display/22843/ at Seoul National University in 2005 following accusations of misconduct.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Andrea Gawrylewski

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution